NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cocoon Bioscience

Cocoon Bioscience

Private
DerioHealthcare & Life Scienceshttps://cocoonbio.com/

Last Round

Series A

Mar 20, 2023

Total Funding Raised

$15.9M

Company Overview

Cocoon Bioscience is a biotechnology company that manufactures recombinant proteins, such as specialty enzymes and growth factors, using insects as natural bioreactors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Biotech Equipment, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

recombinant protein manufacturinginsect bioreactorgrowth factorsspecialty enzymesbiologics CDMOcultivated meat ingredientsbiomanufacturingprotein expression systemBaculovirus Expression Vector SystemBEVSlab-grown meat inputsCrisBio®cellular agriculturesingle-use bioreactorcustom enzyme developmentmRNA therapy components

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cocoon Bioscience Comparables

Compare Cocoon Bioscience with similar companies based on industry and business-model similarity.

Cocoon Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Future Fields
88%
Insud Pharma
79%
Core Biogenesis
78%

Cocoon Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 20, 2023

Key People

Founding team and executive leadership

Romy Moreno Dalton

Chief Operating Officer Directora De Operaciones At Cocoon Bioscience (spin-off Algenex)

Executive Team

Cocoon Bioscience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Grew 16% QoQ, from 37 to 43 employees.

  • May 3, 2025

    Grew 17% QoQ, from 35 to 41 employees.

Cocoon Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cocoon Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cocoon Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersDerio
Employee Range30
Year Founded2022
Last FundingMar 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.